Publicaciones en las que colabora con JOSE LUIS FERNANDEZ MARTIN (101)

2024

  1. Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients

    Nephrology Dialysis Transplantation, Vol. 39, Núm. 4, pp. 618-626

  2. Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease–Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2023

  1. Experimental Models to Study Diabetes Mellitus and Its Complications: Limitations and New Opportunities

    International Journal of Molecular Sciences, Vol. 24, Núm. 12

  2. MicroRNA-145 and microRNA-486 are potential serum biomarkers for vascular calcification

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 7, pp. 1729-1740

  3. Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 11, pp. 2589-2597

  4. Phosphorus May Induce Phenotypic Transdifferentiation of Vascular Smooth Muscle Cells through the Reduction of microRNA-145

    Nutrients, Vol. 15, Núm. 13

  5. Redox Metabolism and Vascular Calcification in Chronic Kidney Disease

    Biomolecules, Vol. 13, Núm. 9

  6. Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes

    International journal of molecular sciences, Vol. 24, Núm. 6

2022

  1. A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial

    BMC medicine, Vol. 20, Núm. 1, pp. 83

2021

  1. Association of biochemical parameters of bone metabolism with progression and/or development of new aortic calcifications

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 13, Núm. 1, pp. 10-16

  2. Effects of calcitriol and paricalcitol on renal fibrosis in CKD

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 36, Núm. 5, pp. 793-803

  3. Fibrosis in chronic kidney disease: Pathogenesis and consequences

    International Journal of Molecular Sciences, Vol. 22, Núm. 1, pp. 1-19

  4. Survival with low- and high-flux dialysis

    Clinical Kidney Journal, Vol. 14, Núm. 8, pp. 1915-1923

  5. The receptor activator of nuclear factor κΒ ligand receptor leucine-rich repeat-containing G-protein-coupled receptor 4 contributes to parathyroid hormone-induced vascular calcification

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 36, Núm. 4, pp. 618-631

2020

  1. Impact of vascular calcification on bone health and mortality in kidney transplant patients

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 12, Núm. 2, pp. 53-61

2019

  1. Serum phosphate optimal timing and range associated with patients survival in haemodialysis: The COSMOS study

    Nephrology Dialysis Transplantation, Vol. 34, Núm. 4, pp. 673-681

2018

  1. Impact of calcium overload on bone and mineral metabolism at 55 hemodialysis centers in Lima

    Nefrologia, Vol. 38, Núm. 3, pp. 279-285

  2. Risk of hospitalization associated with body mass index and weight changes among prevalent haemodialysis patients

    Nefrologia, Vol. 38, Núm. 5, pp. 520-527

2017

  1. Effects of the catalase antioxidant enzyme in vascular calcification and bone demineralization

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 9, Núm. 1, pp. 13-19

2016

  1. COSMOS Project: Hemodialysis scenario in Europe

    Nefrologia, Vol. 36, Núm. 4, pp. 381-388